Author:
Aragon-Ching Jeanny B.,Jain Lokesh,Gulley James L.,Arlen Philip M.,Wright John J.,Steinberg Seth M.,Draper David,Venitz Jürgen,Jones Elizabeth,Chen Clara C.,Figg William D.,Dahut William L.
Reference20 articles.
1. Discovery and development of sorafenib: a multikinase inhibitor for treating cancer;Wilhelm;Nat Rev Drug Discov,2006
2. 2 Pazdur R , Keegan P . FDA Approval for Sorafenib Tosylate, 11/19/07 update. National Cancer Institute. Available at: http://www.cancer.gov/cancertopics/druginfo/fda-sorafenib-tosylate. Accessed February 2008
3. Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group;McDermott;J Clin Oncol,2008
4. Phase I trial of sorafenib and gemcitabine in advanced solid tumors with an expanded cohort in advanced pancreatic cancer;Siu;Clin Cancer Res,2006
5. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma;Weidner;Am J Pathol,1993
Cited by
107 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献